广发中证香港创新药ETF发起式联接(QDII)C(019671)份额变动
| 截止日 |
期初份额(份) |
期末份额(份) |
期间申购份额(份) |
期间赎回份额(份) |
| 2025-06-29 |
154,843,707.54 |
545,628,087.22 |
1,043,412,157.35 |
652,627,777.67 |
| 2025-03-30 |
91,281,885.80 |
154,843,707.54 |
195,126,927.82 |
131,565,106.08 |
| 2024-12-30 |
78,572,614.90 |
91,281,885.80 |
117,343,298.83 |
104,634,027.93 |
| 2024-09-29 |
43,235,720.87 |
78,572,614.90 |
80,221,408.22 |
44,884,514.19 |
| 2024-06-29 |
31,438,102.89 |
43,235,720.87 |
45,230,374.01 |
33,432,756.03 |
| 2024-03-30 |
23,571,670.45 |
31,438,102.89 |
52,519,370.36 |
44,652,937.92 |
| 2023-12-30 |
98,231.17 |
23,571,670.45 |
31,044,012.45 |
7,570,573.17 |
微信公众号
证券之星APP
基本资料
